[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.238.248.103. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
1.
Zhu  N, Zhang  D, Wang  W,  et al; China Novel Coronavirus Investigating and Research Team.  A novel coronavirus from patients with pneumonia in China, 2019.   N Engl J Med. 2020;382(8):727-733. doi:10.1056/NEJMoa2001017PubMedGoogle ScholarCrossref
2.
Coronaviridae Study Group of the International Committee on Taxonomy of Viruses.  The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2.   Nat Microbiol. 2020;5(4):536-544. doi:10.1038/s41564-020-0695-zPubMedGoogle ScholarCrossref
3.
Qi  F, Qian  S, Zhang  S, Zhang  Z.  Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses.   Biochem Biophys Res Commun. 2020;526(1):135-140. doi:10.1016/j.bbrc.2020.03.044PubMedGoogle ScholarCrossref
4.
Wang  D, Hu  B, Hu  C,  et al.  Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China.   JAMA. 2020;323(11):1061. doi:10.1001/jama.2020.1585PubMedGoogle ScholarCrossref
5.
Chu  J, Yang  N, Wei  Y,  et al.  Clinical characteristics of 54 medical staff with COVID-19: a retrospective study in a single center in Wuhan, China.   J Med Virol. Published online March 20, 2020. doi:10.1002/jmv.25793Google Scholar
6.
Kluytmans-van den Bergh  MFQ, Buiting  AGM, Pas  SD,  et al.  Prevalence and clinical presentation of health care workers with symptoms of coronavirus disease 2019 in 2 Dutch hospitals during an early phase of the pandemic.   JAMA Netw Open. 2020;3(5):e209673. doi:10.1001/jamanetworkopen.2020.9673PubMedGoogle Scholar
7.
Cheng  VC-C, Wong  S-C, Yuen  K-Y.  Estimating coronavirus disease 2019 infection risk in health care workers.   JAMA Netw Open. 2020;3(5):e209687. doi:10.1001/jamanetworkopen.2020.9687PubMedGoogle Scholar
8.
Bai  Y, Yao  L, Wei  T,  et al.  Presumed asymptomatic carrier transmission of COVID-19.   JAMA. 2020;323(14):1406-1407. doi:10.1001/jama.2020.2565PubMedGoogle ScholarCrossref
9.
Kimball  A, Hatfield  KM, Arons  M,  et al; Public Health—Seattle & King County; CDC COVID-19 Investigation Team.  Asymptomatic and presymptomatic SARS-CoV-2 infections in residents of a long-term care skilled nursing facility—King County, Washington, March 2020.   MMWR Morb Mortal Wkly Rep. 2020;69(13):377-381. doi:10.15585/mmwr.mm6913e1PubMedGoogle ScholarCrossref
10.
Li  R, Pei  S, Chen  B,  et al.  Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2).   Science. 2020;368(6490):489-493. doi:10.1126/science.abb3221PubMedGoogle ScholarCrossref
11.
Zou  L, Ruan  F, Huang  M,  et al.  SARS-CoV-2 viral load in upper respiratory specimens of infected patients.   N Engl J Med. 2020;382(12):1177-1179. doi:10.1056/NEJMc2001737PubMedGoogle ScholarCrossref
12.
Cheng  H-Y, Jian  S-W, Liu  D-P, Ng  TC, Huang  WT, Lin  HH; Taiwan COVID-19 Outbreak Investigation Team.  Contact tracing assessment of COVID-19 transmission dynamics in Taiwan and risk at different exposure periods before and after symptom onset.   JAMA Intern Med. Published online May 1, 2020. doi:10.1001/jamainternmed.2020.2020PubMedGoogle Scholar
13.
Bi  Q, Wu  Y, Mei  S,  et al.  Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study.   Lancet Infect Dis. Published online April 27, 2020. doi:10.1016/S1473-3099(20)30287-5Google Scholar
14.
Li  W, Zhang  B, Lu  J,  et al.  The characteristics of household transmission of COVID-19.   Clin Infect Dis. Published online April 17, 2020. doi:10.1093/cid/ciaa450PubMedGoogle Scholar
15.
COVID-19 National Emergency Response Center, Epidemiology and Case Management Team, Korea Centers for Disease Control and Prevention.  Coronavirus disease-19: summary of 2,370 contact investigations of the first 30 cases in the Republic of Korea.   Osong Public Health Res Perspect. 2020;11(2):81-84. doi:10.24171/j.phrp.2020.11.2.04PubMedGoogle ScholarCrossref
16.
Lu  J, Gu  J, Li  K,  et al.  COVID-19 outbreak associated with air conditioning in restaurant, Guangzhou, China, 2020.   Emerg Infect Dis. 2020;26(7). doi:10.3201/eid2607.200764PubMedGoogle Scholar
17.
Park  SY, Kim  YM, Yi  S,  et al.  Coronavirus disease outbreak in call center, South Korea.   Emerg Infect Dis J. 2020;26(8). doi:10.3201/eid2608.201274PubMedGoogle Scholar
18.
Hijnen  D, Marzano  AV, Eyerich  K,  et al.  SARS-CoV-2 transmission from presymptomatic meeting attendee, Germany.   Emerg Infect Dis. 2020;26(8). doi:10.3201/eid2608.201235PubMedGoogle Scholar
19.
Hamner  L, Dubbel  P, Capron  I,  et al.  High SARS-CoV-2 attack rate following exposure at a choir practice—Skagit County, Washington, March 2020.   MMWR Morb Mortal Wkly Rep. 2020;69(19):606-610. doi:10.15585/mmwr.mm6919e6PubMedGoogle ScholarCrossref
20.
Liu  Y, Ning  Z, Chen  Y,  et al.  Aerodynamic analysis of SARS-CoV-2 in two Wuhan hospitals.   Nature. Published online April 27, 2020. doi:10.1038/s41586-020-2271-3PubMedGoogle Scholar
21.
Wölfel  R, Corman  VM, Guggemos  W,  et al.  Virological assessment of hospitalized patients with COVID-2019.   Nature. 2020;581(7809):465-469. doi:10.1038/s41586-020-2196-xPubMedGoogle ScholarCrossref
22.
Pan  Y, Zhang  D, Yang  P, Poon  LLM, Wang  Q.  Viral load of SARS-CoV-2 in clinical samples.   Lancet Infect Dis. 2020;20(4):411-412. doi:10.1016/S1473-3099(20)30113-4PubMedGoogle ScholarCrossref
23.
Pasomsub  E, Watcharananan  SP, Boonyawat  K,  et al  Saliva sample as a non-invasive specimen for the diagnosis of coronavirus disease: a cross-sectional study.   Clin Microbiol Infect. Published online May 15, 2020. doi:10.1016/j.cmi.2020.05.001PubMedGoogle Scholar
24.
Zheng  S, Fan  J, Yu  F,  et al.  Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study.   BMJ. 2020;369:m1443. doi:10.1136/bmj.m1443PubMedGoogle ScholarCrossref
25.
Yang  S, Lee  GWM, Chen  C-M, Wu  C-C, Yu  K-P.  The size and concentration of droplets generated by coughing in human subjects.   J Aerosol Med. 2007;20(4):484-494. doi:10.1089/jam.2007.0610PubMedGoogle ScholarCrossref
26.
Johnson  GR, Morawska  L.  The mechanism of breath aerosol formation.   J Aerosol Med Pulm Drug Deliv. 2009;22(3):229-237. doi:10.1089/jamp.2008.0720PubMedGoogle ScholarCrossref
27.
Papineni  RS, Rosenthal  FS.  The size distribution of droplets in the exhaled breath of healthy human subjects.   J Aerosol Med. 1997;10(2):105-116. doi:10.1089/jam.1997.10.105PubMedGoogle ScholarCrossref
28.
Gschwind  S, Graczyk  H, Günther  D, Riediker  M.  A method for the preservation and determination of welding fume nanoparticles in exhaled breath condensate.   Environ Sci Nano. 2016;3(2):357-364. doi:10.1039/C5EN00240KGoogle ScholarCrossref
29.
Sauvain  J-J, Hohl  MSS, Wild  P, Pralong  JA, Riediker  M.  Exhaled breath condensate as a matrix for combustion-based nanoparticle exposure and health effect evaluation.   J Aerosol Med Pulm Drug Deliv. 2014;27(6):449-458. doi:10.1089/jamp.2013.1101PubMedGoogle ScholarCrossref
30.
Willeke  K, Baron  PA, eds.  Aerosol Measurement: Principles, Techniques, and Applications. Van Nostrand Reinhold; 1993.
31.
Monks  T, Currie  CSM, Onggo  BS, Robinson  S, Kunc  M, Taylor  SJE.  Strengthening the reporting of empirical simulation studies: introducing the STRESS guidelines.   J Simul. 2019;13(1):55-67. doi:10.1080/17477778.2018.1442155Google ScholarCrossref
32.
The COVID-19 Investigation Team.  Clinical and virologic characteristics of the first 12 patients with coronavirus disease 2019 (COVID-19) in the United States.   Nat Med. Published online April 23, 2020. doi:10.1038/s41591-020-0877-5PubMedGoogle Scholar
33.
British Standards Institution.  EN 481:1993 Workplace Atmospheres: Size Fraction Definitions for Measurement of Airborne Particles. British Standards Institution; 1993.
34.
Scheff  PA, Paulius  VK, Curtis  L, Conroy  LM.  Indoor air quality in a middle school, part II: development of emission factors for particulate matter and bioaerosols.   Appl Occup Environ Hyg. 2000;15(11):835-842. doi:10.1080/10473220050175715PubMedGoogle ScholarCrossref
35.
van Doremalen  N, Bushmaker  T, Morris  DH,  et al.  Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1.   N Engl J Med. 2020;382(16):1564-1567. doi:10.1056/NEJMc2004973PubMedGoogle ScholarCrossref
36.
Hsu  JY, Stone  RA, Logan-Sinclair  RB, Worsdell  M, Busst  CM, Chung  KF.  Coughing frequency in patients with persistent cough: assessment using a 24 hour ambulatory recorder.   Eur Respir J. 1994;7(7):1246-1253. doi:10.1183/09031936.94.07071246PubMedGoogle ScholarCrossref
37.
Lippmann  M, Yeates  DB, Albert  RE.  Deposition, retention, and clearance of inhaled particles.   Br J Ind Med. 1980;37(4):337-362. doi:10.1136/oem.37.4.337PubMedGoogle Scholar
38.
Beardsell  I, ed.  Get Through MCEM Part A: MCQs. CRC Press; 2009.
39.
Ramos  CA, Reis  JF, Almeida  T, Alves  F, Wolterbeek  HT, Almeida  SM.  Estimating the inhaled dose of pollutants during indoor physical activity.   Sci Total Environ. 2015;527-528:111-118. doi:10.1016/j.scitotenv.2015.04.120PubMedGoogle ScholarCrossref
40.
Yezli  S, Otter  JA.  Minimum infective dose of the major human respiratory and enteric viruses transmitted through food and the environment.   Food Environ Virol. 2011;3(1):1-30. doi:10.1007/s12560-011-9056-7PubMedGoogle ScholarCrossref
41.
Asadi  S, Wexler  AS, Cappa  CD, Barreda  S, Bouvier  NM, Ristenpart  WD.  Aerosol emission and superemission during human speech increase with voice loudness.   Sci Rep. 2019;9(1):2348. doi:10.1038/s41598-019-38808-zPubMedGoogle ScholarCrossref
42.
Patel  RB, Skaria  SD, Mansour  MM, Smaldone  GC.  Respiratory source control using a surgical mask: an in vitro study.   J Occup Environ Hyg. 2016;13(7):569-576. doi:10.1080/15459624.2015.1043050PubMedGoogle ScholarCrossref
43.
Grosskopf  KR, Herstein  KR.  The aerodynamic behavior of respiratory aerosols within a general patient room.   HVAC & R Res. 2012;18(4):709-722.Google Scholar
44.
Chen  M-J, Chang  K-J, Hsu  C-C, Lin  P-Y, Liu  CJ-L.  Precaution and Prevention of Coronavirus Disease 2019 (COVID-19) Infection in the Eye.   J Chin Med Assoc. Published online April 21, 2020. doi:10.1097/JCMA.0000000000000334PubMedGoogle Scholar
45.
Kim  J-O, Kim  W-S, Kim  S-W,  et al.  Development and application of quantitative detection method for viral hemorrhagic septicemia virus (VHSV) genogroup IVa.   Viruses. 2014;6(5):2204-2213. doi:10.3390/v6052204PubMedGoogle ScholarCrossref
46.
Edwards  DA, Man  JC, Brand  P,  et al.  Inhaling to mitigate exhaled bioaerosols.   Proc Natl Acad Sci U S A. 2004;101(50):17383-17388. doi:10.1073/pnas.0408159101PubMedGoogle ScholarCrossref
47.
Holmgren  H, Bake  B, Olin  A-C, Ljungström  E.  Relation between humidity and size of exhaled particles.   J Aerosol Med Pulm Drug Deliv. 2011;24(5):253-260. doi:10.1089/jamp.2011.0880PubMedGoogle ScholarCrossref
48.
Chang  T-J, Hsieh  Y-F, Kao  H-M.  Numerical investigation of airflow pattern and particulate matter transport in naturally ventilated multi-room buildings.   Indoor Air. 2006;16(2):136-152. doi:10.1111/j.1600-0668.2005.00410.xPubMedGoogle ScholarCrossref
Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words
    2 Comments for this article
    EXPAND ALL
    Viral copies significantly overestimates infection risk
    Richard Falk, No PhD | No Affiliation
    The use of viral RNA copies significantly overestimates infection risk. For a variety of reasons including the innate immune system, not all measured RNA will be in infectious virions. Furthermore, TCID50 measurement using Vero E6 cells do not account for the innate immune system of the recipient (i.e. the infectious dose may be greater than 1 TCID50).

    For SARS-CoV (original SARS from 2003), there were 360 RNA copies per PFU which is roughly 250 TCID50 (based on Poisson-based ln(2) = 0.693 TCID50/PFU) for cultured virus [ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3322807/ ]. For SARS-CoV-2, hACE2 transgenic mice had both RNA
    copies/mL and TCID50/mL measured from lung samples at the viral load peak of 3 days past infection (in an infectious dose study) where 10^6.77 = 5,890,000 RNA copies/mL corresponded with 10^2.44 TCID50 / 100 µL = 2754 TCID50/mL implying 2140 RNA copies per TCID50 [ https://www.nature.com/articles/s41586-020-2312-y ]. These conversions result in 2 or 3 orders of magnitude reduction in infectiousness with respect to Vero E6 cell cultures.

    In addition, there is also a factor for the infectious dose which is not 1 TCID50. In the same transgenic mice study noted above, straddle challenge doses for inhaled aerosol showed no mice infected at 720 or lower TCID50 and all mice infected at 900 or higher TCID50. A maximum likelihood dose I calculated from the study data gives a 726 TCID60 estimate for 50% probability of infection. This is another factor of 2 to 3 orders of magnitude.

    Using the volume of droplets in the fine aerosol fraction combined with the presumed concentration of infectious virions does not result in enough to infect at the attack rates since in well-mixed enclosed environment outbreak events. Yet long-distance aerosol events are seen so there must be other factors. The infective dose in humans may be lower than found in the transgenic mice study and/or there may be concentration enhancement in the smaller aerosols and/or the counts and volumes of the finest aerosol fraction may be undercounted.
    CONFLICT OF INTEREST: None Reported
    READ MORE
    Excellent Study
    John Murphy, MHSc PhD ROH CIH MACE | University of Toronto Dalla Lana School of Public Health
    A useful study that converges on the question of the range of infectious doses. It would be good to ascertain the relationship between virus concentrations in the fluid lining the bronchioles / alveoli and concentrations in sputum / oral fluid, in order to refine the modeled aerosol virus concentrations and infectious doses.
    CONFLICT OF INTEREST: None Reported
    Views 21,561
    Citations 0
    Original Investigation
    Occupational Health
    July 27, 2020

    Estimation of Viral Aerosol Emissions From Simulated Individuals With Asymptomatic to Moderate Coronavirus Disease 2019

    Author Affiliations
    • 1Swiss Centre for Occupational and Environmental Health, Winterthur, Switzerland
    • 2Department of Child and Adolescent Psychiatry and Psychotherapy, University Hospital of Psychiatry, University of Zurich, Zurich, Switzerland
    JAMA Netw Open. 2020;3(7):e2013807. doi:10.1001/jamanetworkopen.2020.13807
    Key Points español 中文 (chinese)

    Question  What is the estimated viral load released from an individual with coronavirus disease 2019 (COVID-19) by breathing and coughing, and what is the resulting concentration in a room?

    Findings  In this mathematical modeling study, breathing and coughing by a simulated individual with COVID-19 were estimated to release large numbers of viruses in a poorly ventilated room with a coughing person. However, the estimated infectious risk posed by a person with typical viral load who breathes normally was low, and only few people with very high viral load posed an infection risk in a poorly ventilated closed environment.

    Meaning  These results may partially explain the observed rates of transmission and suggest that there is a need for strict respiratory protection when people are in the same room with an individual with COVID-19.

    Abstract

    Importance  Individuals with asymptomatic or mild coronavirus disease 2019 (COVID-19) have been reported to frequently transmit the disease even without direct contact. The severe acute respiratory syndrome coronavirus 2 has been found at very high concentrations in swab and sputum samples from such individuals.

    Objective  To estimate the virus levels released from individuals with asymptomatic to moderate COVID-19 into different aerosol sizes by normal breathing and coughing, and to determine what exposure could result from this in a room shared with such individuals.

    Design, Setting, and Participants  This mathematical modeling study combined the size-distribution of exhaled breath microdroplets for coughing and normal breathing with viral swab and sputum concentrations as approximation for lung lining liquid to obtain an estimate of emitted virus levels. Viral data were obtained from studies published as of May 20, 2020. The resulting emission data fed a single-compartment model of airborne concentrations in a room of 50 m3, the size of a small office or medical examination room.

    Main Outcomes and Measures  Modeling was used to estimate the viral load emitted by individuals breathing normally or coughing, and the concentrations expected in the simulated room at different ventilation rates.

    Results  The mean estimated viral load in microdroplets emitted by simulated individuals while breathing regularly was 0.0000049 copies/cm3, with a range of 0.0000000049 to 0.637 copies/cm3. The corresponding estimates for simulated coughing individuals were a mean of 0.277 copies/cm3 per cough, with a range of 0.000277 to 36 030 copies/cm3 per cough. The estimated concentrations in a room with an individual who was coughing frequently were very high, with a maximum of 7.44 million copies/m3 from an individual who was a high emitter. However, regular breathing from an individual who was a high emitter was modeled to result in lower room concentrations of up to 1248 copies/m3.

    Conclusions and Relevance  In this modeling study, breathing and coughing were estimated to release large numbers of viruses, ranging from thousands to millions of virus copies per cubic meter in a room with an individual with COVID-19 with a high viral load, depending on ventilation and microdroplet formation process. The estimated infectious risk posed by a person with typical viral load who breathes normally was low. The results suggest that only few people with very high viral load pose an infection risk in poorly ventilated closed environments. These findings suggest that strict respiratory protection may be needed when there is a chance to be in the same small room with an individual, whether symptomatic or not, especially for a prolonged period.

    ×